Cidara
portfoliocompanies
company snapshot

Cidara Therapeutics (Nasdaq: CDTX) is applying its small molecule immunotherapy platform to treat life-threatening illnesses exacerbated by deficiencies of the human immune system. Cidara's initial focus is on devastating fungal infections that often complicate cancer and transplant treatments.